Thomas Templeman - 01 Feb 2022 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Reporting relationship: Chief Technology Officer
Issuer ticker: CNTA
Reported as of: 01 Feb 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Feb 2022, 17:30:29 UTC
Prior SEC filing: 04 Jun 2021
Next SEC filing: 06 Jul 2022
Source filing: View source filing
Reporting owner signature: /s/ Marella Thorell, attorney-in-fact

Key filing fact

Thomas Templeman filed Form 4 for Centessa Pharmaceuticals plc (CNTA) on 03 Feb 2022.

Key facts

This page summarizes Thomas Templeman's Form 4 filing for Centessa Pharmaceuticals plc (CNTA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 03 Feb 2022, 17:30.

Change

Previous filing in this sequence was filed on 04 Jun 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CNTA transaction Derivative

Share Option (right to buy)

Award

Transaction value: $0
Shares: +140,000
Change %
Price: $0.000000
Shares after: 140,000
Date: 01 Feb 2022
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 140,000
Exercise price: $9.53
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

11,664 shares subject to such option shall vest and become exercisable on June 1,2022 and the remaining 128,336 shares subject to such option shall vest and become exercisable in 44 substantially equal installments on each monthly anniversary thereafter.

Footnote F2

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.